Last SFr.116.10 CHF
Change Today -0.50 / -0.43%
Volume 183.6K
ATLN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
SIX Swiss Ex
OTC US
As of 10:38 AM 12/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Paul Clozel M.D.

Founder, Chief Executive Officer, Member of Management Board and Director, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 3 different organizations across 3 different industries.

See Board Relationships
59SFr.6,355,848
As of Fiscal Year 2013

Background*

Mr. Jean-Paul Clozel, MD founded Actelion Pharmaceuticals U.S., Inc. in 1997 and has been its Chief Executive Officer since April 2000. Mr. Clozel is the Founder of Actelion Ltd., (Actelion AG ) and has been its Chief Executive Officer since 1999 and serves as its Member of Management Board. He was a Practicing Cardiologist for 11 years, from 1974 to 1985. He served as the Head of Drug Discovery Group in the Cardiovascular Department of F. Hoffmann-La Roche for 12 years, ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Founder, Chief Executive Officer, Member of Management Board and Director
Founder, Chief Executive Officer, Member of The Board and Member of Executive Committee
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

SalarySFr.1,130,721
BonusSFr.1,469,937
Total Annual CompensationSFr.2,600,658

Stock Options*

Restricted Stock AwardsSFr.1,505,778
All Other CompensationSFr.2,249,412

Total Compensation*

Total Annual Cash CompensationSFr.4,850,070
Total Short Term CompensationSFr.2,600,658
Other Long Term CompensationSFr.3,755,190
Total Calculated CompensationSFr.6,355,848
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.116.10 CHF -0.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Martine A. Rothblatt Ph.D., MBA, J.D.Founder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$992.7K
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB S.A.
€2.1M
Jörg-Thomas Dierks Chief Executive Officer
Meda AB
kr2.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.